Drug intelligence / Profile preview

B-FIT

Development stage: Unknown
Lead developer: Dr. Johns Laboratories
Modality: Small Molecules
Administration: Oral

Overview

B-FIT (also known as B-FIT with B12) is an oral vitamin B12 supplement developed and marketed by the German pharmaceutical company T&D Pharma. As a dietary supplement, it is primarily indicated for the management of vitamin B12 deficiency and for general dietary supplementation. Vitamin B12 (cobalamin) is a critical water-soluble vitamin that serves as a cofactor for enzymes such as methionine synthase and methylmalonyl-CoA mutase, which are essential for DNA synthesis, red blood cell formation, and the maintenance of the central nervous system. B-FIT is part of T&D Pharma's over-the-counter (OTC) portfolio and is administered orally to support cellular energy production and neurological health.

Other names: Vitamin B12 supplement

Targets

MMUT (Methylmalonyl-coenzyme A mutase)MTR (Methionine synthase)

Beyond the preview

Go deeper on B-FIT.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on B-FIT.

Explore the full profile